Search - tctmd.com

Displaying 481 - 500 of 665

Sort: Relevancy | Date

Presentation TCT 2016

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Joseph F. Sabik

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Severe AS and Chronic Kidney Disease

Presenter: Howard C. Herrmann, Vinod H. Thourani, Molly Szerlip

October 31, 2016

Presentation TCT 2016

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

Low Frequency Therapeutic Ultrasound (LOTUS) to Improve Outcomes of Acute and Chronic Kidney Disease (Sonogenix)

Presenter: Lawrence A. Garcia, Jihad A. Mustapha, Michael Dae

October 30, 2016

News Daily News

Midlife Hypertension Linked to Late-Life Cognitive Decline

Leah Lawrence

October 11, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Industry News

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

September 16, 2016

News Daily News

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

Michael O'Riordan

September 16, 2016

News Daily News

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Shelley Wood

September 13, 2016

News Daily News

Stroke Not the Only Concern in Patients With A-fib

Todd Neale

September 07, 2016

News Conference News ESC 2016

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Michael O'Riordan

August 27, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Shelley Wood

July 19, 2016

News Daily News

Precious Time: Questionable Treatments Often Used at the End of Life

Todd Neale

June 30, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Advertisement

EXCEL Outcomes in Patients With and Without Chronic Kidney Disease

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Severe AS and Chronic Kidney Disease

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Low Frequency Therapeutic Ultrasound (LOTUS) to Improve Outcomes of Acute and Chronic Kidney Disease (Sonogenix)

Midlife Hypertension Linked to Late-Life Cognitive Decline

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease

Semaglutide Cuts Risk of Major Cardiovascular Events in Type 2 Diabetes: SUSTAIN-6

TAVR 伴随中风风险：PARTNER 研究深入审查和 CoreValve 数据揭示了机遇和未知

Stroke Not the Only Concern in Patients With A-fib

Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say

Precious Time: Questionable Treatments Often Used at the End of Life

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content